Hyperemesis Gravidarum Treatment Approach
For hyperemesis gravidarum, the last resort treatment options include corticosteroids, mirtazapine, olanzapine, gabapentin, and enteral or parenteral nutrition when all conventional therapies have failed. 1, 2
Initial Assessment and Management
Assessment
- Evaluate severity using the Pregnancy-Unique Quantification of Emesis (PUQE) score:
- Mild (≤6 points)
- Moderate (7-12 points)
- Severe (≥13 points) 1
- Check for dehydration signs: orthostatic hypotension, decreased skin turgor, dry mucous membranes
- Monitor weight loss (>5% of pre-pregnancy weight indicates severe condition)
- Assess for electrolyte imbalances and nutritional deficiencies 1
First-Line Management
Dietary modifications:
- Small, frequent, bland meals
- BRAT diet (bananas, rice, applesauce, toast)
- High-protein, low-fat meals
- Avoid spicy, fatty, acidic, and fried foods
- Small, frequent sips of fluid 1
First-line medications:
- Vitamin B6 (pyridoxine) 10-25 mg every 8 hours
- Doxylamine 10-20 mg at bedtime or every 8 hours
- Ginger 250 mg capsule 4 times daily 1
Escalation of Treatment
Second-Line Medications
- H1-receptor antagonists (promethazine, dimenhydrinate)
- Metoclopramide for moderate to severe cases
- Ondansetron (use with caution in early first trimester due to small risk of orofacial clefts [0.03%] and ventricular septal defects [0.3%]) 1
Hospitalization Criteria
Hospitalize patients with:
- Dehydration
- Weight loss >5% of pre-pregnancy weight
- Electrolyte imbalances 1
Inpatient Management
- IV fluid and electrolyte replacement
- IV thiamine supplementation (100 mg daily for minimum 7 days, followed by 50 mg daily until adequate oral intake)
- IV antiemetics (ondansetron or metoclopramide)
- Use routine around-the-clock administration rather than PRN dosing
- Consider multiple concurrent agents in alternating schedules or routes 1
Last Resort Treatment Options
When conventional therapies fail, consider:
Corticosteroids:
- Methylprednisolone or prednisolone for refractory cases
- Important: Avoid before 10 weeks gestation due to increased risk of oral clefts 1
Alternative pharmacotherapeutics:
Nutritional support:
- Enteral nutrition: When oral intake is not tolerated for prolonged periods with ongoing weight loss
- Parenteral nutrition: Ultimate last resort when all other options have failed and nutritional status is severely compromised 2
Important Considerations and Pitfalls
- Avoid NK-1 antagonists like aprepitant due to limited human data in pregnancy, especially injection formulations containing ethanol 1
- Nutritional monitoring is critical as patients often have suboptimal biochemical status of thiamine, riboflavin, vitamin B6, vitamin A, and retinol-binding protein 4
- Medication timing: Use routine around-the-clock administration rather than PRN dosing for breakthrough treatment 1
- Route of administration: Consider rectal or IV therapy when oral route is not feasible 1
- Multivitamin supplementation is essential during treatment to correct deficiencies 4
- For patients with adjustable gastric banding: Consider band deflation to prevent band slippage and nutrient deficiencies 1
The treatment approach should follow a stepwise algorithm, starting with first-line treatments and progressing to more aggressive interventions only when necessary. The ultimate goal is to maintain adequate hydration, nutrition, and medication tolerance while minimizing risks to both mother and fetus.